These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 8938664

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
    Piros ET, Prather PL, Loh HH, Law PY, Evans CJ, Hales TG.
    Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
    [Abstract] [Full Text] [Related]

  • 6. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
    Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, Vogel Z.
    J Biol Chem; 1996 Aug 30; 271(35):21309-15. PubMed ID: 8702909
    [Abstract] [Full Text] [Related]

  • 7. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect?
    Khasar SG, Wang JF, Taiwo YO, Heller PH, Green PG, Levine JD.
    Neuroscience; 1995 Jul 30; 67(1):189-95. PubMed ID: 7477899
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. mu-Opioid receptor stimulation of inositol (1,4,5)trisphosphate formation via a pertussis toxin-sensitive G protein.
    Smart D, Smith G, Lambert DG.
    J Neurochem; 1994 Mar 30; 62(3):1009-14. PubMed ID: 8113787
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes.
    Ma GH, Miller RJ, Kuznetsov A, Philipson LH.
    Mol Pharmacol; 1995 May 30; 47(5):1035-40. PubMed ID: 7746270
    [Abstract] [Full Text] [Related]

  • 13. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
    Clark MJ, Traynor JR.
    J Pharmacol Exp Ther; 2005 Feb 30; 312(2):809-15. PubMed ID: 15383633
    [Abstract] [Full Text] [Related]

  • 14. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
    Nijssen PC, Sexton T, Childers SR.
    J Neurochem; 1992 Dec 30; 59(6):2251-62. PubMed ID: 1331327
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase.
    Fedynyshyn JP, Lee NM.
    FEBS Lett; 1989 Aug 14; 253(1-2):23-7. PubMed ID: 2547657
    [Abstract] [Full Text] [Related]

  • 17. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    Roerig SC, Loh HH, Law PY.
    Mol Pharmacol; 1992 May 14; 41(5):822-31. PubMed ID: 1317000
    [Abstract] [Full Text] [Related]

  • 18. Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor.
    Cavalli A, Babey AM, Loh HH.
    Neuroscience; 1999 May 14; 93(3):1025-31. PubMed ID: 10473267
    [Abstract] [Full Text] [Related]

  • 19. 3H-naloxone benzoylhydrazone binding in MOR-1-transfected Chinese hamster ovary cells: evidence for G-protein-dependent antagonist binding.
    Brown GP, Pasternak GW.
    J Pharmacol Exp Ther; 1998 Jul 14; 286(1):376-81. PubMed ID: 9655882
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS, Werling LL, Cox BM.
    Mol Pharmacol; 1988 May 14; 33(5):520-7. PubMed ID: 2835651
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.